Delivery of pharmaceutical products for SBALHZ in 4 lots
Original notice title
Доставка на лекарствени продукти за нуждите на СБАЛХЗ ЕАД по 4 обособени позиции
Opportunity Score
Why this score?
Opportunity
50 / 100
Complexity
70 / 100
Risk factors
Only 15 days to prepare and submit a compliant bid, including gathering required licenses.
Missing lot descriptions and procurement documents make it difficult to assess full scope and conditions.
Submission deadline in 1 days
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- EUR 573.7k estimated value
- Supplies contract
- 3 lots
- Duration 24 MONTH
- Supply of pharmaceutical products to SBALHZ EAD, Sofia, Bulgaria.
- Four lots covering different pharmaceutical products as per technical specification (not analyzed).
Show full summary
Open tender for the supply of pharmaceutical products to the Specialized Hospital for Active Treatment of Hematological Diseases (SBALHZ) in Sofia, Bulgaria, divided into 4 lots. Awarded on a lowest-price basis per lot. The tender has a tight 15-day submission deadline from publication.
Risks
Only 15 days to prepare and submit a compliant bid, including gathering required licenses.
Missing lot descriptions and procurement documents make it difficult to assess full scope and conditions.
Submission deadline in 1 days
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Tenderers can bid for all lots (maximum 4 lots).
Administrative
- Submission via electronic platform (Open portal).
- Tenders must be in Bulgarian language.
Requirements may be incomplete.
Award Criteria
Lot 1
Lot 2
Lot 3
Lot 4
Buyer
Name
СПЕЦИАЛИЗИРАНА БОЛНИЦА ЗА АКТИВНО ЛЕЧЕНИЕ НА ХЕМАТОЛОГИЧНИ ЗАБОЛЯВАНИЯ ЕАД
Location
гр. София, BGR
Buyer profile
Identifier
200105779
Lots (4)
LOT-0001
Meropenem
Meropenem 1000 mg, parenteral form, estimated quantity 60,000,000 mg.
EUR 306k
Estimated value
Location
Duration
Category
Selection criteria
Deadline
Award details
Additional CPV codes
Value note
Show original TED data
Original TED description
Meropenem 1000 mg, парентерална форма, прогнозно количество - 60 000 000 mg
LOT-0002
Siltuximab
No lot title or description provided. Main CPV 33600000, additional CPV 33652100.
EUR 53.3k
Estimated value
Location
Duration
Category
Selection criteria
Deadline
Award details
Additional CPV codes
Value note
Show original TED data
Original TED description
Siltuximab100 mg, парентерална форма, прогнозно количество -12 000 mg
LOT-0003
Siltuximab
No lot title or description provided. Main CPV 33600000, additional CPV 33652100.
EUR 213.4k
Estimated value
Location
Duration
Category
Selection criteria
Deadline
Award details
Additional CPV codes
Value note
Show original TED data
Original TED description
Siltuximab 400 mg, парентерална форма, прогнозно количество- 48 000 mg
LOT-0004
Cyanocobalamin
Cyanocobalamin 1000 mcg/ml - 1 ml, парентерална форма, прогнозно количество - 1 200 mg
EUR 976
Estimated value
Location
Duration
Category
Selection criteria
Award details
Additional CPV codes
Procurement Details
- Publication date
- 10 Jun 2026
- Notice type
- Contract notice — standard
- Languages
- Bulgarian
Reference metadata
- Notice subtype
- 16
- Notice version
- 1
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 401492-2026
- Source notice ID
- dbe48ebe-022a-4f07-b594-18cd0a60013a
Documents (1)
Similar tenders
Poland – Various medicinal products – ZP.220.99.26 Dostawa różnych produktów leczniczych, żywności medycznej oraz preparatów do żywienia pacjentów na potrzeby
Poland – Antineoplastic agents – Dostawa produktów leczniczych i wyrobów medycznych do Wojskowego Instytutu Medycznego – PIB
Poland – Antineoplastic agents – Leki onkologiczne i sprzęt pomocniczy
Poland – Antithrombotic agents – Dostawa produktów leczniczych do leczenia zaburzeń w funkcjonowaniu przewodu pokarmowego, środków antybakteryjnych do użytku ogólnoustrojowego (...) w podziale na 21 części.
Romania – Antineoplastic agents – achizitia de medicamente utilizate in tratamentul pacientilor beneficiari ai Programului Programului national de oncologie-Subprogramul de tratament medicamentos al bolnavilor cu afectiuni oncologice (adulti si copii), Programul national de oncologie medicamente COST-VOLUM
Romania – Various medicinal products – ACORD CADRU FURNIZARE MEDICAMENTE SI SOLUTII PERFUZABILE 24 LUNI
Opportunity Score
Why this score?
Opportunity
50 / 100
Complexity
70 / 100
Risk factors
Only 15 days to prepare and submit a compliant bid, including gathering required licenses.
Missing lot descriptions and procurement documents make it difficult to assess full scope and conditions.
Submission deadline in 1 days
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications